Table 4 HZ-Health care resources consumption by global COPD (with and without ICS) and COPD-ICS patients in relation with Non-COPD
From: Risk and impact of herpes zoster among COPD patients: a population-based study, 2009–2014
COPD | COPD-ICS | |
|---|---|---|
Outpatient visits for HZ | RR (95% CI) | |
1.05 (1.03–1.08) | 1.07 (1.03–1.1) | |
Medication for HZ | RR (95% CI) | |
1.25 (1.19–1.31) | 1.45 (1.32–1.59) | |
Hospitalizationsa | OR (95% CI) | |
2.66 (2.17–3.24) | 2.59 (1.80–3.62) | |
Length of hospital stay | Mean ratio (95% CI) | |
1.21 (0.97–1.52) | 1.26 (0.84–1.87) | |
Sick leave | Mean ratio (95% CI) | |
1.06 (0.62–1.82) | 1.06 (0.34–3.29) | |